INFORMATION:
The article can be downloaded from the following link:
http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=1962
Research team proves the efficacy of new drug against stem cells that provoke the growth of cancer
The new drug, called Bozepinib, has been successfully tested in mice
2014-11-26
(Press-News.org) An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of relapse after chemotherapy and metastasis. This drug, called Bozepinib, has proved to be effective in tests with mice. The results have been published in the prestigious journal Oncotarget.
Cancerogenic stem cells appear in small quantities in tumours, and one of their important features is that they contribute to the formation of metastasis in different places within the original tumour. Cancerogenic stem cells remain dormant under normal conditions (i.e. they do not divide). Conventional chemotherapy and radiotherapy act upon those cancer cells which are clearly differentiated--i.e. which are undergoing processes of division--but they cannot destroy these dormant cancerogenic stem cells. Actually, after a positive initial response to treatment, many cancer patients suffer a relapse because these cancerogenic stem cells have not been destroyed.
During the last few years, research in fight against cancer has focused on the search for new drugs that can selectively attack these cancerogenic stem cells. If they can be eliminated, the tumour will then be eliminated in its entirety, which will lead to the complete curation of patients.
Scientists in the "Advanced therapies: differentiation, regeneration and cancer" research group led by UGR professor Juan Antonio Marchal have collaborated with Joaquín Campos, from the School of Pharmacy, U. of Granada, and María Ángeles García, from Virgen de las Nieves University Hospital in Granada, as well as with the universities of Jaen and Miami (US) to develop the new drug Bozepinib.
Clinical tests on patients
This new drug shows a selective type of activity against cancerogenic stem cells in breast, colon, and skin cancers. "The powerful anti-tumour activity of Bozepinib is due to the inhibition of the HER2 signalling pathway, and to the fact that this drug inhibits the invasiveness and the formation of new vessels in the tumour (angiogenesis)", says prof. Juan Antonio Marchal. Researchers have also revealed the specific mechanism by means of which Bozepinib acts against cancerogenic stem cells
This new drug proved to be nontoxic for healthy mice when it was intraperitoneally or orally administered, and it also inhibited tumoural growth and the formation of lung metastasis in those mice in which the tumour was induced.
Researchers are currently conducting safety tests and they expect that this new drug, as well as its derivatives, can be run through clinical tests with actual patients in the near future.
ELSE PRESS RELEASES FROM THIS DATE:
Diverting a river from ecological disaster in northwestern China could provide new sustainable model
2014-11-26
For tens of thousands of years, modern humans have used the waterways to spread out across the surface of the planet. Major civilizations developed along massive rivers like the Nile in Egypt and the Yellow River in China, and massive water channels propelled the expansion of economies around the world. But in recent decades, according to a team of scientists at the Cold and Arid Regions Environmental and Engineering Research Institute, Chinese Academy of Sciences, in the northwestern Chinese city of Lanzhou, the competition between economic growth and the ecosystem of ...
Young scientist discovers new method to achieve ultra-narrow laser linewidth
2014-11-26
Chongqing, China--Dr. Tao Zhu and his team of researchers from Chongqing University, Southwest China, have discovered a new method to highly compress laser linewidth based on Rayleigh backscattering. Using their new method, Rayleigh backscattering can be collected in any waveguide structure and all wave bands to effectively compress a laser linewidth to merely hundreds of hertz, which could have a revolutionary impact on the field of laser technology. This makes it possible for portable laser devices to achieve an ultra-narrow linewidth at room temperature, which until ...
Hacked emails slice spam fast
2014-11-26
Spam spreads much faster and to more people when it is being propagated by hacked, or otherwise compromised, email accounts rather than legitimate accounts, according to research published in the International Journal of Security and Networks. The insight should help those modeling the dynamics of information diffusion as well as those hoping to track and trace spam with a view to slowing or blocking its propagation. Spam traditionally contained ads for fake or counterfeit products, but currently also contains disruptive rumors and information of a political nature.
Ghita ...
Glassy protein solution may cause eyesight deterioration
2014-11-26
Long-sightedness caused by age could be due to proteins in the lens of the eye that are converted from a fluid solution to a solid, glassy state. This has been shown in a study by researchers from institutions including Lund University.
Around the age of 40-50, many people find their sight deteriorates and they need to use reading glasses. This age-related long-sightedness is thought to be due to a reduction in the elasticity of the lens in the eye. A new research study appears to have put its finger on the details of what happens in the eye when long-sightedness develops.
"This ...
New guide to the genetic jungle of muscles can help health research
2014-11-26
How do the genes in the cells inside the body's muscles respond when the muscles are put to work? And how are these genes affected when muscles are not used? What importance do activity and, on the other hand, lack of activity have for the organism's metabolism, and thus also for diseases such as diabetes and obesity?
These questions form the basis for a new study from the Department of Public Health at Aarhus University and the Institute of Sports Medicine at Bispebjerg Hospital. For the first time, the study compares the reactions of all genes in the muscles to diverse ...
New international collaboration investigates the Laguna del Maule Volcanic Field, Chile
2014-11-26
Boulder, Colorado, USA - The Laguna del Maule Volcanic Field, Chile, includes a record of unusually large and recent concentration of silicic eruptions. Since 2007, the crust there has been inflating at an astonishing rate of 25 centimeters per year. This unique opportunity to investigate the dynamics of a large rhyolitic system while magma migration, reservoir growth, and crustal deformation are actively under way is stimulating a new international collaboration.
Explosive eruptions of large-volume rhyolitic magma systems are common in the geologic record and pose a ...
Process converts human waste into rocket fuel
2014-11-26
GAINESVILLE, Fla. --- Buck Rogers surely couldn't have seen this one coming, but at NASA's request, University of Florida researchers have figured out how to turn human waste -- yes, that kind -- into rocket fuel.
Adolescent jokes aside, the process finally makes useful something that until now has been collected to burn up on re-entry. What's more, like so many other things developed for the space program, the process could well turn up on Earth, said Pratap Pullammanappallil, a UF associate professor of agricultural and biological engineering.
"It could be used on ...
New research shows sportswomen still second best to sportsmen...in the press!
2014-11-26
DESPITE a sequence of stellar performances by Britain's female athletes and team game players, coverage of women's sport in the Press still occupies a fraction of the space given to men, according to University of Huddersfield lecturer Deirdre O'Neill, who has analysed thousands of articles in newspapers that she describes as a "football-saturated boyzone".
One side effect of this marginalisation of women's sport is that girls - with fewer role models to admire - are much less likely to take part themselves. They leave school half as active as young men, leading to potential ...
Bioengineering study finds two-cell mouse embryos already talking about their future
2014-11-26
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types. Their research, which used single-cell RNA sequencing to look at every gene in the mouse genome, was published recently in the journal Genome Research. In addition, this group published a paper on analysis of "time-course"single-cell data ...
New evidence of ancient rock art across Southeast Asia
2014-11-26
Latest research on the oldest surviving rock art of Southeast Asia shows that the region's first people, hunter-gatherers who arrived over 50,000 years ago, brought with them a rich art practice.
Published this week in the archaeological journal Antiquity, the research shows that these earliest people skilfully produced paintings of animals in rock shelters from southwest China to Indonesia. Besides these countries, early sites were also recorded in Thailand, Cambodia and Malaysia.
Griffith University Chair in Rock Art Professor Paul Taçon led the research which ...
LAST 30 PRESS RELEASES:
Post-LLM era: New horizons for AI with knowledge, collaboration, and co-evolution
“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot
Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows
USC researchers observe mice may have a form of first aid
VUMC to develop AI technology for therapeutic antibody discovery
Unlocking the hidden proteome: The role of coding circular RNA in cancer
Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC
Study reveals widening heart disease disparities in the US
The role of ubiquitination in cancer stem cell regulation
New insights into LSD1: a key regulator in disease pathogenesis
Vanderbilt lung transplant establishes new record
Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine
Metasurface technology offers a compact way to generate multiphoton entanglement
Effort seeks to increase cancer-gene testing in primary care
Acoustofluidics-based method facilitates intracellular nanoparticle delivery
Sulfur bacteria team up to break down organic substances in the seabed
Stretching spider silk makes it stronger
Earth's orbital rhythms link timing of giant eruptions and climate change
Ammonia build-up kills liver cells but can be prevented using existing drug
New technical guidelines pave the way for widespread adoption of methane-reducing feed additives in dairy and livestock
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
New study finds that tooth size in Otaria byronia reflects historical shifts in population abundance
nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip
Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure
Fluoride in drinking water is associated with impaired childhood cognition
New composite structure boosts polypropylene’s low-temperature toughness
While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains
Revolutionizing surface science: Visualization of local dielectric properties of surfaces
LearningEMS: A new framework for electric vehicle energy management
Nearly half of popular tropical plant group related to birds-of-paradise and bananas are threatened with extinction
[Press-News.org] Research team proves the efficacy of new drug against stem cells that provoke the growth of cancerThe new drug, called Bozepinib, has been successfully tested in mice